Published 12:06 IST, September 15th 2020

China's coronavirus vaccines may be ready for use by November: Official

China's COVID-19 vaccines may be ready for the general public's use by November this year, said country's chief biosafety expert Guizhen Wu.

Reported by: Vishal Tiwari
Follow: Google News Icon
  • share
null | Image: self
Advertisement

China's COVID-19 vaccines may be rey for general public's use by vember this year, said country's chief biosafety expert Guizhen Wu. During an interview with state-run TV on September 14, Wu said that coronavirus vaccines are on Phase 3 of clinical trials and if everything goes well y may be rey by vember or December this year. China has developed four vaccines, all of which are in final st of clinical trials, according to health authorities in country. 

Re: COVID-19 Vaccine Manufacturing Has Begun At A Risk, Will Be Rey By Year-end: Pfizer CEO

Advertisement

China has even iculated its medical workers with one of four vaccines being tested in country, as per local media reports. medical workers were given vaccine under emergency use programme launched in July. Wu, during interview, also said that she has taken vaccine herself and so far hasn't experienced any verse effects from it. Wu, who is an official with China Centre for Disease Control and Prevention (CDC), did t specify which vaccine she took.

Re: Spain To Host Phase 2 Clinical Trial Of Johnson & Johnson-me Coronavirus Vaccine

Advertisement

People's Liberation Army (PLA) in June h approved use of a COVID-19 vaccine that it h developed in association with Chinese pharmaceutical firm CanSi Biologics. vaccine was approved for military even before it could go through Phase III clinical trials. or three vaccines in China have been developed by state-owned National Pharmaceutical Group (Sipharm) and private company Sivac Biotech. 

Re: 'Animal Trials Of COVID-19 Vaccine Candidate Covaxin Successful': Bharat Biotech

Advertisement

Vaccine development across globe

Meanwhile, re are currently more than 110 COVID-19 vaccines being developed across world, which are in various sts of development. According to World Health Organisation (WHO), most vanced candidate among se was AstraZeneca's AZD1222, which it was developing in partnership with Oxford University. vaccine, however, suffered a set back last week after makers h to stop trials because a volunteer fell ill. trials have resumed again with a hope that it will be rey by end of 2020 or by January next year. 

Re: Mexico Signs A Deal Of 32-million Doses Of Russia's Sputnik V COVID-19 Vaccine
 

Advertisement

12:07 IST, September 15th 2020